Skip to main content
Torrent Pharmaceuticals Ltd. logo

Torrent Pharmaceuticals Ltd. — Investor Relations & Filings

Ticker · TORNTPHARM ISIN · INE685A01028 LEI · 335800NA6HK275RIJE13 BSE.NS Manufacturing
Open in API
Filings indexed 1,765 across all filing types
Latest filing 2021-11-17 Regulatory Filings
Country IN India
Listing BSE.NS TORNTPHARM

About Torrent Pharmaceuticals Ltd.

https://www.torrentpharma.com

Torrent Pharmaceuticals Ltd. is a research-driven organization focused on the development, manufacturing, and marketing of generic formulations. The company holds a significant position in therapeutic areas such as cardiovascular, central nervous system, gastrointestinal, diabetology, and anti-infective treatments. It has strategically expanded its portfolio into dermatology, nephrology, and pain management through targeted acquisitions. The firm operates across multiple international markets, supported by advanced research and development centers and manufacturing facilities that adhere to global regulatory standards. Its core operations prioritize chronic therapy leadership and the provision of high-quality healthcare solutions through a robust pipeline of generic and value-added medicines.

Recent filings

Filing Released Lang Actions
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges (BSE and NSE) regarding the loss of share certificates by shareholders. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and includes details about the lost certificates and the process for issuing duplicates. The content is an official notification about share certificate loss and related compliance, not a financial report, earnings release, or management discussion. It does not contain financial statements or results, nor does it announce voting results or capital changes. This type of document fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous compliance and regulatory announcements that do not fit other specific categories.
2021-11-17 English
Intimation of Schedule of Investor Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Capital/Financing Update Classification · 90% confidence The document is a letter addressed to stock exchanges (BSE and NSE) regarding the schedule of upcoming investor meetings. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content is about notifying the schedule of investor meets, not about financial results, reports, or management changes. The document length is short (1573 characters) and it is an announcement of a schedule, not a report or detailed presentation. Therefore, it fits best under Capital/Financing Update (CAP) as it relates to investor relations activities and disclosures about meetings with investors.
2021-11-11 English
Analysts/Institutional Investor Meet/Con. Call Updates
Capital/Financing Update Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) regarding the schedule of upcoming investor meetings. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content is an announcement of the schedule of investor meetings, not a financial report, earnings release, or detailed presentation. The document length is short (1573 characters) and it is an announcement of an event rather than a report or transcript. Therefore, it fits best under Capital/Financing Update (CAP) as it relates to investor meetings and disclosures about company interactions with investors.
2021-11-11 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) notifying them of the schedule of upcoming investor meetings. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content is about informing the exchanges and public about planned investor interactions, not about financial results, reports, or management changes. The document length is short (1573 characters), and it is an announcement of a schedule rather than a report or detailed presentation. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-11-11 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) regarding the schedule of upcoming investor meetings. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content is about notifying the schedule of investor meetings, not the actual investor presentation or report. The document length is short (1598 characters), and it is an announcement of an event schedule rather than a detailed report or presentation. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-11-11 English
Intimation of rescheduling of Investor/Analyst Meet In furtherance to our letter dated 27-Oct-21 on the captioned subject, we would like to inform that the Investors / Analyst ....
Regulatory Filings Classification · 95% confidence The document is a short letter addressed to stock exchanges informing about the rescheduling of an Investor/Analyst Meet. It does not contain any financial data, report content, or detailed presentation material. It is essentially an announcement regarding the timing of an event related to investor relations. The document length is only 1361 characters, which is quite short and fits the pattern of an announcement rather than a full report or presentation. Therefore, it is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-11-11 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.